SCHEMBL4777418

SCHEMBL4777418

CNCCc1sc2ccccc2c1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.52
CHRM1 P11229 2/20 0.52
HRH1 P35367 2/20 0.52
KCNH2 Q12809 1/20 0.52
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
TAAR1 Q96RJ0 5/20 0.41
ATM Q13315 1/20 0.41
LOXL2 Q9Y4K0 1/20 0.40
HTR2A P28223 2/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HTR1A P08908 1/20 0.39
HTT P42858 1/20 0.39
GPR3 P46089 1/20 0.39
CHRNB2 P17787 3/20 0.36
CHRNA7 P36544 3/20 0.36
CHRNA4 P43681 3/20 0.36
HRH3 Q9Y5N1 1/20 0.36
PRNP P04156 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1253465 0.82 TAS1R3 (0.47) CYP2D6CHRM1HRH1KCNH2TAS1R3
SCHEMBL2387916 0.80 CNR2 (0.49) TAS1R3TAS1R1ATMLOXL2ALDH1A1
SCHEMBL1035524 0.78 LOXL2 (0.48) CYP2D6TAS1R3TAS1R1LOXL2ALDH1A1
SCHEMBL2388976 0.76 CNR2 (0.46) TAS1R3TAS1R1ATMLOXL2ALDH1A1
SCHEMBL12507999 0.75 TAS1R3 (0.41) TAS1R3TAS1R1LOXL2ALDH1A1GPR3
SCHEMBL4429817 0.75 CNR2 (0.51) KCNH2TAS1R3TAS1R1LOXL2ALDH1A1
SCHEMBL586085 0.74 GPR3 (0.44) TAS1R3TAS1R1LOXL2ALDH1A1GPR3
SCHEMBL2702753 0.74 LOXL2 (0.63) TAS1R3TAS1R1LOXL2ALDH1A1KDM4E
SCHEMBL719251 0.74 GPR3 (0.44) TAS1R3TAS1R1ATMLOXL2ALDH1A1
SCHEMBL6323143 0.74 TAS1R3 (0.49) TAS1R3TAS1R1LOXL2ALDH1A1GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973902-A2 3-HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS Affinium Pharmaceuticals, Inc. (CA) 2008-10-01 EP disclosed
WO-2007067416-A2 HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS AFFINIUM PHARMACEUTICALS, INC. (CA) 2007-06-14 WO disclosed